BACKGROUND AND OBJECTIVES

Historically, cholecystectomy was infrequently performed in children. Lifestyle changes, delays in health care access, and increases in childhood obesity occurred during the COVID-19 pandemic. The impact of these shifts on need for cholecystectomy are poorly understood. We evaluate trends in cholecystectomy case volume among children during the COVID-19 pandemic.

METHODS

A multi-institutional retrospective cohort study was conducted for children ages 18 years and younger who underwent cholecystectomy from January 1, 2016, to July 31, 2022, at 10 children’s hospitals. Differences in cholecystectomy case mix and volume before and during the pandemic were identified using bivariate comparisons and interrupted time series analysis.

RESULTS

Overall, 4282 children were identified: 2122 before the pandemic and 2160 during the pandemic. Most were female (74.2%) with a median age of 15 years (IQR, 13.0–16.0 years). The proportion of Hispanic (55.0% vs 60.1%; P = .01) patients, body mass index (BMI) (26.0 vs 27.1; P < .001), and obesity (BMI > 30) (30.8% vs 37.4%; P < .001) increased during the pandemic. Predicted monthly case volume increased from 40 to 100 during the pandemic. Patients transferred from an outside hospital increased (21.3% vs 28.5%; P < .001). Significant increases in acute cholecystitis (12.2% vs 17.3%; P < .001), choledocholithiasis (12.8% vs 16.5%; P = .001), gallstone pancreatitis (10.6% vs 12.4%; P = .064), and chronic cholecystitis (1.4% vs 3.2%; P < .001) also occurred. On interrupted time series analysis, change in month-to-month case count significantly increased during the pandemic (Figure 1; P < .001), which persisted after exclusion of transferred patients.

CONCLUSIONS

Pediatric cholecystectomy case volume and complexity increased during the COVID-19 pandemic. These findings may be secondary to changes in childhood health, transfer patterns, and shifts in access, highlighting an increased health care burden on children’s hospitals.

What’s Known on This Subject:

Historically, cholecystectomy has been infrequently performed in children. Lifestyle changes, delays in health care access, and increases in childhood obesity occurred during the COVID-19 pandemic. The impact of these shifts on the need for pediatric cholecystectomy are poorly understood.

What This Study Adds:

Pediatric cholecystectomy case volume and complexity increased during the COVID-19 pandemic. These findings are likely secondary to changes in childhood health, transfer and referral patterns, and overall shifts in health care access, highlighting the increased utilization and importance of children’s hospitals.

Historically, biliary disease was considered rare in children, but more recent studies highlight increased cholecystectomy rates.1–6 During the COVID-19 pandemic, many adults scheduled for elective surgery experienced delays in care, with notable increases in inpatient admissions for biliary disease.7–11 Although we continue to learn more about COVID-19 infection, little is known about the collateral and downstream effects of the COVID-19 pandemic in children. Delays in elective surgery, emergency department and hospital avoidance, mandatory stay-at-home policies, and transfer patterns between adult and pediatric hospitals may impact utilization of pediatric surgical care.

For children, in addition to surgical delays, stay-at-home policies may have limited access to regular exercise and healthy meals. Multiple studies demonstrate a decrease in physical activity and significant changes in diet associated with an increase in childhood obesity during the pandemic.12–22 These epidemiologic findings are notable as increased weight and poor dietary habits are associated with biliary disease. A recent single-center study from a Western Pediatric Surgery Research Consortium (WPSRC) member hospital noted a significant increase in pediatric cholecystectomy during the COVID-19 pandemic.23 However, it is unknown whether this increase in the need for cholecystectomy is occurring within the larger pediatric population.

Our goal was to examine the effects of the COVID-19 pandemic on pediatric biliary disease requiring cholecystectomy. We hypothesized that the number of pediatric cholecystectomies performed and the complexity of biliary disease cared for at children’s hospitals increased after the start of the COVID-19 pandemic.

A multi-institutional, retrospective cohort study was conducted for children ages 18 years and younger who underwent cholecystectomy from January 1, 2016, to July 31, 2022, at 10 children’s hospitals within WPSRC. Each institution’s electronic medical record (EMR) was queried for the following Current Procedural Terminology codes for cholecystectomy: 47 562, 47 563, 47 564, 43 260, 43 261, 43 263, 43 264, 43 265, 43 274, 43 275, 43 276, 43 277, and 43 278. Children who underwent cholecystectomy for congenital biliary anomalies (including biliary atresia), gallbladder polyps, or oncologic resections or during liver transplantation were excluded (Figure 1). The beginning of the pandemic was defined as March 19, 2020, when the first statewide mandatory stay-at-home policies went into effect. The prepandemic group included patients who underwent cholecystectomy from January 1, 2016, to March 19, 2020, whereas the during-pandemic group was from March 20, 2020, to July 31, 2022. January 1, 2016, was selected as the start date to ensure adequate years to establish prepandemic trend and patterns. The study was individually approved by each WPSRC site’s institutional review board.

FIGURE 1.

Flow diagram of study cohort.

Abbreviation: n, sample size.
FIGURE 1.

Flow diagram of study cohort.

Abbreviation: n, sample size.
Close modal

The demographic and clinical factors of the patients collected from review of the EMR included age, race and ethnicity, sex, body mass index (BMI), insurance/payer status, Area Deprivation Index (ADI), and chronic medical conditions (obesity defined as BMI higher than 30, sickle cell anemia, beta thalassemia, hereditary spherocytosis, other anemia, cystic fibrosis, and cardiac disease). Surgical indication was determined by review of the operative report, surgeon’s description of findings, and diagnosis. All those classified as “acute cholecystitis” had findings of gallstones. Patients with “acalculus cholecystitis” did not have gallstones. Additional factors regarding the surgical encounter were collected including endoscopic retrograde cholangiopancreatography (ERCP) performed (Y/N), magnetic resonance cholangiopancreatography (MRCP) performed (Y/N), laparoscopic vs open surgery, inpatient vs outpatient surgery, and transfer status. Transfer status was defined as patients who underwent interfacility transfer for inpatient surgery.

Race and ethnicity are recognized as social constructs and were included as certain minoritized groups have experienced disproportionately higher rates of COVID-19 infection, hospitalization, COVID-19–related mortality, and unemployment during the pandemic.24,25 Including race and ethnicity facilitated our ability to evaluate the unequal burden the COVID-19 pandemic placed on patients from marginalized populations. Race and ethnicity categories were defined according to availability in individual hospitals’ EMR. Each hospital reported race and ethnicity data for each visit according to institutional practices and thus may include parent/guardian reporting at time of admission. Patients with missing race and/or ethnicity data were categorized as “unknown/not reported,” separate from the “other” category.

The ADI was determined for each patient and deidentified using the University of Wisconsin School of Medicine and Public Health website.26 The ADI ranks neighborhoods based upon 17 indicators from the American Community Survey, which encompasses information on socioeconomic domains including education, economic, housing, social, food security, and transportation.27–29 The ADI score correlates with access to pediatric surgical care and was used as a proxy for socioeconomic disadvantage.30,31 ADI national rankings (0–100) were reported as median/IQR and divided into tertiles (low, moderate, and high) with the highest tertile representing greater socioeconomic disadvantage.

The primary outcome of interest was cholecystectomy case volume defined by number of cholecystectomies performed per month. The secondary outcomes included surgical indication as indication of complexity of biliary disease and transfer status. Postoperative outcomes were also evaluated, including length of stay (days), postoperative complications (pancreatitis, common bile duct injury, retained stone, cholangitis, pneumonia, deep venous thrombosis [DVT], urinary tract infection [UTI], bleeding), readmissions within 30 days of discharge, and indication for readmission (superficial surgical site infection, intraabdominal abscess, bowel injury, cholangitis/retained stone, common bile duct injury, pneumonia, UTI, DVT, bile leak, bleeding, pain control). All variables were obtained via a standardized manual chart review of the EMR at all sites.

Continuous variables were described using median and IQR, and Wilcoxon-Mann-Whitney tests were used to compare the groups. Categorical variables were described using frequencies and percentages with χ2 or Fischer’s exact tests used to compare the groups. Nonparametric tests were used for data that were not normally distributed. The total monthly number of cholecystectomies performed was compared between the prepandemic and pandemic groups, with trends evaluated by interrupted time series (ITS) analysis using the autoregressive integrated moving average model to account for the correlated observations taken over time.32,33 ITS modeling is a robust method for evaluating interventions or critical events at a population level by accounting for underlying trends, autocorrelation, and seasonality, although patient-specific variables are not included in the model.34 The ITS analysis was selected to determine whether the case volume trends observed in the analysis significantly deviated from those that would have been expected before the COVID-19 pandemic. The impact of the COVID-19 pandemic was evaluated by the change in the level (immediate step change) and trend of the monthly number of cholecystectomies performed. As a sensitivity analysis, the ITS was repeated with a subgroup of the cohort excluding patients who were transferred from a referring hospital for inpatient surgery. A P value of less than .05 was considered significant. Data analysis was performed using SAS software version 9.4 (SAS Institute Inc).

The cohort consisted of 4282 patients: 2122 in the prepandemic group and 2160 in the pandemic group. Most patients were female (74.5%), Hispanic (57.6%), and publicly-insured (64.6%) with a median age of 15 years (IQR, 13.0–16.0 years). Children and adolescents who underwent cholecystectomy during the pandemic had significantly higher BMI values than those undergoing cholecystectomy before the pandemic (26.0 kg/m2 vs 27.1 kg/m2; P < .001). The distribution of race and ethnicity differed between the 2 groups (P = .009; Table 1). Notably, although Hispanic patients made up the majority of prepandemic and during-pandemic groups, the proportion of Hispanic patients increased during the pandemic (55.0% vs 60.1%; Table 1). Irrespective of group, most patients fell into the least-disadvantaged ADI tertile (score: 0–39), and the proportion between ADI tertiles differed by pandemic period (P = .01; Table 1). The number of patients with chronic medical conditions predisposing to biliary disease, including sickle cell anemia (3.5% vs 2.3%; P = .02), beta thalassemia (0.3% vs 0%; P = .02), hereditary spherocytosis (3.7% vs 2.0%; P = .001), and cystic fibrosis (0.5% vs 0.1%; P = .02), decreased during the pandemic. Obesity was more common during the pandemic (30.8% vs 37.4%; P < .001; Table 1).

TABLE 1.

Demographics and Clinical Factors for Total Cohort, Prepandemic, and Pandemic Groups

Demographic and Clinical FactorsTotal N = 4282Prepandemic n = 2122Pandemic n = 2160P Value
MedianIQRMedianIQRMedianIQR
Age 15 13–16 15 13–16 15 13–16 .001 
BMI 26.5 21.8–32.4 26 21.1–31.7 27.1 22.5–32.9 <.001 
  
Biologic sex       .30 
 Female 3178 74.2 1560 73.5 1618 74.9  
 Male 1104 25.8 562 26.5 542 25.1  
Race and ethnicity       .009 
 White 1060 24.8 568 26.8 492 22.8  
 Black/African American 274 6.4 146 6.9 128 5.9  
 Asian 55 1.3 23 1.1 32 1.5  
 Hispanic 2465 57.6 1167 55 1298 60.1  
 Other 316 7.4 164 7.7 152  
 Unknown/not reported 112 2.6 54 2.5 58 2.7  
Insurance type       .002 
 Private 1244 29.1 650 30.6 594 27.5  
 Government 2765 64.6 1313 61.9 1452 67.2  
 Military 31 0.7 14 0.7 17 0.8  
 None/self-pay 80 1.9 52 2.5 28 1.3  
 Multiple 144 3.4 75 3.5 69 3.2  
ADI        
 National (median, IQR) 34 19–58 34 19–60 35 20–57 .93 
National ADI tertiles       .012 
 Low (0–39) 2395 55.9 1197 56.4 1198 55.5  
 Moderate (40–59) 829 19.4 376 17.7 453 21.0  
 High (≥60) 1033 24.1 539 25.4 494 22.9  
Chronic medical conditions        
 Obesity (BMI > 30) 1460 34.1 653 30.8 807 37.4 <.001 
 Cardiac 78 1.8 44 2.1 34 1.6 .22 
 Sickle cell anemia 124 2.9 74 3.5 50 2.3 .02 
 Anemia (other) 94 2.2 53 2.5 41 1.9 .18 
 Beta thalassemia 0.1 0.3 0.0 .02 
 Hereditary spherocytosis 122 2.8 78 3.7 44 2.0 .001 
 Cystic fibrosis 12 0.3 10 0.5 0.1 .02 
 None 2421 56.5 1234 58.2 1187 55.0 .04 
 Unknown 18 0.4 10 0.5 0.4 .61 
Demographic and Clinical FactorsTotal N = 4282Prepandemic n = 2122Pandemic n = 2160P Value
MedianIQRMedianIQRMedianIQR
Age 15 13–16 15 13–16 15 13–16 .001 
BMI 26.5 21.8–32.4 26 21.1–31.7 27.1 22.5–32.9 <.001 
  
Biologic sex       .30 
 Female 3178 74.2 1560 73.5 1618 74.9  
 Male 1104 25.8 562 26.5 542 25.1  
Race and ethnicity       .009 
 White 1060 24.8 568 26.8 492 22.8  
 Black/African American 274 6.4 146 6.9 128 5.9  
 Asian 55 1.3 23 1.1 32 1.5  
 Hispanic 2465 57.6 1167 55 1298 60.1  
 Other 316 7.4 164 7.7 152  
 Unknown/not reported 112 2.6 54 2.5 58 2.7  
Insurance type       .002 
 Private 1244 29.1 650 30.6 594 27.5  
 Government 2765 64.6 1313 61.9 1452 67.2  
 Military 31 0.7 14 0.7 17 0.8  
 None/self-pay 80 1.9 52 2.5 28 1.3  
 Multiple 144 3.4 75 3.5 69 3.2  
ADI        
 National (median, IQR) 34 19–58 34 19–60 35 20–57 .93 
National ADI tertiles       .012 
 Low (0–39) 2395 55.9 1197 56.4 1198 55.5  
 Moderate (40–59) 829 19.4 376 17.7 453 21.0  
 High (≥60) 1033 24.1 539 25.4 494 22.9  
Chronic medical conditions        
 Obesity (BMI > 30) 1460 34.1 653 30.8 807 37.4 <.001 
 Cardiac 78 1.8 44 2.1 34 1.6 .22 
 Sickle cell anemia 124 2.9 74 3.5 50 2.3 .02 
 Anemia (other) 94 2.2 53 2.5 41 1.9 .18 
 Beta thalassemia 0.1 0.3 0.0 .02 
 Hereditary spherocytosis 122 2.8 78 3.7 44 2.0 .001 
 Cystic fibrosis 12 0.3 10 0.5 0.1 .02 
 None 2421 56.5 1234 58.2 1187 55.0 .04 
 Unknown 18 0.4 10 0.5 0.4 .61 

Abbreviations: ADI, Area Deprivation Index; BMI, body mass index; n, sample size.

Changes in surgical indication for cholecystectomy were observed between the prepandemic and during-pandemic groups (Table 2). Symptomatic cholelithiasis (56.1 vs 45.6%; P < .001) and biliary dyskinesia (6.2% vs 4.3%; P = .005) as an indication for cholecystectomy decreased during the pandemic, and an increase in cholecystectomy for complicated biliary disease was observed. Significant increases in cholecystectomy for acute cholecystitis (12.2% vs 17.3%; P < .001), choledocholithiasis (12.8% vs 16.5%; P = .001), and chronic cholecystitis (1.4% vs 3.2%; P < .001) occurred during the pandemic. Although not statistically significant, a higher proportion of gallstone pancreatitis was reported during the pandemic (10.6% vs 12.4%; P = .06). Although MRCP utilization increased in the during-pandemic group (14.3% vs 17.7%; P = .003), there was no significant difference in the proportion of ERCPs performed (18.0% vs 18.8%; P = .53) (Table 2).

TABLE 2.

Perioperative and Postoperative Outcomes for Total Cohort, Prepandemic, and Pandemic Groups

Perioperative and Postoperative VariablesTotal N = 4282Prepandemic n = 2122Pandemic n = 2160P Value
n%n%n%
Surgical indication        
 Symptomatic cholelithiasis 2176 50.8 1190 56.1 986 45.6 <.001 
 Acute cholecystitis 632 14.8 258 12.2 374 17.3 <.001 
 Cholangitis 17 0.4 0.4 0.4 .84 
 Choledocholithiasis 629 14.7 272 12.8 357 16.5 .001 
 Acalculous cholecystitis 12 0.3 0.4 0.2 .26 
 Biliary dyskinesia 225 5.3 132 6.2 93 4.3 .005 
 Gallstone pancreatitis 491 11.5 224 10.6 267 12.4 .06 
 Chronic cholecystitis 100 2.3 30 1.4 70 3.2 <.001 
MRCP performed 686 16 304 14.3 382 17.7 .003 
ERCP performed 787 18.4 382 18.0 405 18.8 .53 
ERCP timing       .05 
 Before cholecystectomy 577 73.3 267 69.9 310 76.5  
 During cholecystectomy 94 11.9 55 14.4 39 9.6  
 After cholecystectomy 101 12.8 54 14.1 47 11.6  
Transfer from outside hospital 1068 24.9 452 21.3 616 28.5 <.001 
Surgery settinga       <.001 
 Outpatient 1842 43 984 46.4 858 39.7  
 Inpatient 2344 54.7 1042 49.1 1302 60.3  
Type of cholecystectomy       .36 
 Laparoscopic 4255 99.4 2111 99.5 2144 99.3  
 Open 27 0.01 11 0.52 16 0.74  
Length of stay (median, IQR) 2–4 2–4 1–4 .003 
Postoperative complicationb        
 Pancreatitis 31 0.7 12 0.6 19 0.9 .23 
 CBD injury 0.1 0.1 0.0 .62 
 Retained stone 76 1.8 44 2.1 32 1.5 .14 
 Cholangitis 0.0 0.1 0.0 .25 
 Pneumonia 0.1 0.0 0.1 .63 
 UTI 0.0 0.0 0.0 .50 
 Bleeding 16 0.4 11 0.5 0.2 .12 
 None 3792 88.6 1981 93.4 1811 83.8 <.001 
Readmission within 30 d       .045 
 Unknown 159 3.7 146 6.9 13 0.6  
 No 3895 91.0 1852 87.3 2043 94.6  
 Yes 228 5.3 124 5.8 104 4.8  
Readmission indicationc        
 Superficial SSI 2.2 3.2 1.0 .38 
 Intraabdominal abscess 2.2 3.2 1.0 .38 
 Cholangitis/retained stone 64 28.1 29 23.4 35 33.7 .09 
 Pneumonia 0.4 0.0 1.0 .46 
 UTI 0.9 0.8 1.0 1.00 
 Bile leak 3.5 2.4 4.8 .47 
 Bleeding 10 4.4 4.0 4.8 1.00 
 Pain control 62 27.2 43 34.7 19 18.3 .006 
 Other 101 44.3 50 40.3 51 49.0 .23 
Perioperative and Postoperative VariablesTotal N = 4282Prepandemic n = 2122Pandemic n = 2160P Value
n%n%n%
Surgical indication        
 Symptomatic cholelithiasis 2176 50.8 1190 56.1 986 45.6 <.001 
 Acute cholecystitis 632 14.8 258 12.2 374 17.3 <.001 
 Cholangitis 17 0.4 0.4 0.4 .84 
 Choledocholithiasis 629 14.7 272 12.8 357 16.5 .001 
 Acalculous cholecystitis 12 0.3 0.4 0.2 .26 
 Biliary dyskinesia 225 5.3 132 6.2 93 4.3 .005 
 Gallstone pancreatitis 491 11.5 224 10.6 267 12.4 .06 
 Chronic cholecystitis 100 2.3 30 1.4 70 3.2 <.001 
MRCP performed 686 16 304 14.3 382 17.7 .003 
ERCP performed 787 18.4 382 18.0 405 18.8 .53 
ERCP timing       .05 
 Before cholecystectomy 577 73.3 267 69.9 310 76.5  
 During cholecystectomy 94 11.9 55 14.4 39 9.6  
 After cholecystectomy 101 12.8 54 14.1 47 11.6  
Transfer from outside hospital 1068 24.9 452 21.3 616 28.5 <.001 
Surgery settinga       <.001 
 Outpatient 1842 43 984 46.4 858 39.7  
 Inpatient 2344 54.7 1042 49.1 1302 60.3  
Type of cholecystectomy       .36 
 Laparoscopic 4255 99.4 2111 99.5 2144 99.3  
 Open 27 0.01 11 0.52 16 0.74  
Length of stay (median, IQR) 2–4 2–4 1–4 .003 
Postoperative complicationb        
 Pancreatitis 31 0.7 12 0.6 19 0.9 .23 
 CBD injury 0.1 0.1 0.0 .62 
 Retained stone 76 1.8 44 2.1 32 1.5 .14 
 Cholangitis 0.0 0.1 0.0 .25 
 Pneumonia 0.1 0.0 0.1 .63 
 UTI 0.0 0.0 0.0 .50 
 Bleeding 16 0.4 11 0.5 0.2 .12 
 None 3792 88.6 1981 93.4 1811 83.8 <.001 
Readmission within 30 d       .045 
 Unknown 159 3.7 146 6.9 13 0.6  
 No 3895 91.0 1852 87.3 2043 94.6  
 Yes 228 5.3 124 5.8 104 4.8  
Readmission indicationc        
 Superficial SSI 2.2 3.2 1.0 .38 
 Intraabdominal abscess 2.2 3.2 1.0 .38 
 Cholangitis/retained stone 64 28.1 29 23.4 35 33.7 .09 
 Pneumonia 0.4 0.0 1.0 .46 
 UTI 0.9 0.8 1.0 1.00 
 Bile leak 3.5 2.4 4.8 .47 
 Bleeding 10 4.4 4.0 4.8 1.00 
 Pain control 62 27.2 43 34.7 19 18.3 .006 
 Other 101 44.3 50 40.3 51 49.0 .23 

Abbreviations: CBD, common bile duct; ERCP, endoscopic retrograde cholangiopancreatography; MRCP, magnetic resonance cholangiopancreatography; n, sample size; PE, pulmonary embolism; SSI, surgical site infection; UTI, urinary tract infection.

a

n = 96 missing observations in prepandemic group.

b

No occurrences of the following postoperative complications: deep venous thrombosis.

c

Readmission indication percentage calculated out of those who had a readmission within 30 days. No occurrences of the following readmission indications: deep venous thrombosis/PE, bowel injury, or CBD injury.

During the pandemic, a greater proportion of patients were transferred from a referring hospital for inpatient cholecystectomy during the same hospitalization (21.3% vs 28.5%; P < .001). There was also a significant difference in the type of surgical encounter (outpatient vs inpatient) between the groups, with an increased proportion of inpatient encounters (49.1% vs 60.3%; P < .001) (Table 2). There was no significant difference in the proportion of cholecystectomies performed laparoscopically vs open during the pandemic (99.5% and 99.3%; P = .36).

The median length of stay of both prepandemic and pandemic groups was 2 days (prepandemic IQR, 2.0–4.0; pandemic IQR, 1.0–4.0) with the pandemic group skewed to a slightly shorter length of stay (P = .003) (Table 2). Fewer postoperative complications were reported before the pandemic (no postoperative complications: 93.4% vs 83.8%; P < .001). However, on individual examination of common complications after cholecystectomy, such as retained stone, cholangitis, common bile duct injury, pancreatitis, and bleeding, there were no significant differences between groups (Table 2). Among patients who had a readmission within 30 days, there was a decrease in the proportion of patients with readmission reason secondary to pain control during the pandemic (34.7% vs 18.3%; P = .006) (Table 2).

Raw cholecystectomy case counts increased after the start of the pandemic at each institution (Supplemental Table 1). When evaluating cholecystectomy case volume via ITS analysis, there were significant differences in the prepandemic and pandemic groups (Table 3; Figure 2). Before the pandemic, the average monthly cholecystectomy case count was 40.08 (95% CI, 36.32–43.85) and there was no significant change in month-to-month case volume trend over time (0.08; 95% CI, −0.05 to 0.21; P = .19). Immediately following March 19, 2020, the monthly case count increased by 4.32 (95% CI, −2.12 to 10.75). After the start of the pandemic period, the month-to-month case volume trend significantly increased by 1.69 (95% CI, 1.36–2.01; P < .001). To determine whether the significant increase in cholecystectomies was secondary to a change in transfer patterns from adult to children’s hospitals, a sensitivity analysis excluding transferred patients was performed. Even when excluding patients transferred for cholecystectomy, a significant increase in case volume during the pandemic remained (Table 3; Figure 3; P < .001). Finally, when stratified by individual children’s hospital, cholecystectomy case volume increased at each institution during the pandemic (Figure 4).

TABLE 3.

Interrupted Time Series Analysis of Prepandemic and Pandemic Cholecystectomy Case Volume of All Patients and Excluding Patients Who Were Transferred From an Outside Hospital

VariableEstimate95% CIP Value
All patients 
Cholecystectomies per month before COVID-19 40.08 (36.32–43.85) <.001 
Monthly change in cholecystectomies per month before COVID-19 0.08 (−0.05 to 0.21) .20 
Monthly change in cholecystectomies per month during COVID-19 (compared to pre–COVID-19) 1.69 (1.36–2.01) <.001 
Excluding patients transferred from OSH 
Cholecystectomies per month before COVID-19 27.43 (24.13–30.73) <.001 
Monthly change in cholecystectomies per month before COVID-19 0.15 (0.03–0.26) .01 
Monthly change in cases per month during COVID-19 (compared to pre–COVID-19) 1.03 (0.71–1.35) <.001 
VariableEstimate95% CIP Value
All patients 
Cholecystectomies per month before COVID-19 40.08 (36.32–43.85) <.001 
Monthly change in cholecystectomies per month before COVID-19 0.08 (−0.05 to 0.21) .20 
Monthly change in cholecystectomies per month during COVID-19 (compared to pre–COVID-19) 1.69 (1.36–2.01) <.001 
Excluding patients transferred from OSH 
Cholecystectomies per month before COVID-19 27.43 (24.13–30.73) <.001 
Monthly change in cholecystectomies per month before COVID-19 0.15 (0.03–0.26) .01 
Monthly change in cases per month during COVID-19 (compared to pre–COVID-19) 1.03 (0.71–1.35) <.001 

Abbreviation: OSH, outside hospital.

FIGURE 2.

Interrupted time series analysis of pre–COVID-19 and during–COVID-19 pandemic case volume.

FIGURE 2.

Interrupted time series analysis of pre–COVID-19 and during–COVID-19 pandemic case volume.

Close modal
FIGURE 3.

Interrupted time series analysis of pre–COVID-19 and during–COVID-19 pandemic case volume excluding patients who were transferred from an outside hospital.

FIGURE 3.

Interrupted time series analysis of pre–COVID-19 and during–COVID-19 pandemic case volume excluding patients who were transferred from an outside hospital.

Close modal
FIGURE 4.

Monthly cholecystectomy case count by institution (deidentified).

FIGURE 4.

Monthly cholecystectomy case count by institution (deidentified).

Close modal

Our study demonstrates a considerable and continuing increase in the month-to-month case volume of cholecystectomies for children during the first 2.5 years of the COVID-19 pandemic. Additionally, children undergoing cholecystectomy were more likely to present with complicated biliary disease and were more likely to undergo MRCP imaging. Consistent with national trends, children undergoing cholecystectomy during the pandemic had significantly higher BMIs and increased rates of obesity.12–22 Finally, the significant increase in case volume persisted even when excluding children transferred for inpatient surgery. These findings may represent broader shifts in the epidemiology of pediatric biliary disease and lasting changes in health care utilization that occurred during and persisted after the COVID-19 pandemic.

In the past, pediatric biliary disease necessitating cholecystectomy was uncommon and primarily associated with hemolytic disorders.3 In recent decades, an increase in the incidence of pediatric cholecystectomy has been observed.1–6,35 Historically, the increase in volume in the United States was thought to be driven by increases in biliary dyskinesia.6,36–38 More recent literature shows that symptomatic cholelithiasis from nonhemolytic gallstones is now most common, which is largely attributed to the obesity epidemic in children.5,6,39 Although not the focus of the present study, regional practice patterns may also be indicated by our findings as the definition of biliary dyskinesia is heterogeneous.40 Although the rise in case volume noted in our study may reflect the natural progression of these trends seen over the last few decades, the changes in surgical indication reported in our study deviate from those previously described. During the pandemic, we observed that the number of children undergoing cholecystectomy for symptomatic cholelithiasis, biliary dyskinesia, or hematologic disorders decreased during the pandemic. More complicated biliary disease, including acute cholecystitis, choledocholithiasis, and chronic cholecystitis, increased. Additionally, our study’s findings are not consistent with ongoing national trends,35–38 and instead demonstrate that after the onset of the COVID-19 pandemic, the cholecystectomy case volume increase was abrupt and statistically significant. Adult studies examining the impact of delayed cholecystectomy during the COVID-19 pandemic demonstrated a similar increase in the severity of biliary disease presentations and inpatient admissions.7–11 The increases in complicated biliary disease as surgical indications for cholecystectomy may explain why more cases were performed during a period of halting elective operations. Additionally, we report a decrease in readmissions related to pain control, which may be further indicative of health care avoidance during the COVID-19 pandemic.

In addition to the effects of health care avoidance and delayed surgical intervention, mandatory stay-at-home policies for COVID-19 may have impacted key risk factors for the development of pediatric biliary disease. Multiple studies have shown that the COVID-19 lockdown led to increased screen time, reduced physical activity, and dietary changes among children.12,13,15–22 Moreover, existing literature points to an increase in pediatric BMI and the prevalence of obesity in the United States.12–16 A retrospective study using data from Kaiser Permanente Southern California revealed significant weight gain during the pandemic, particularly in 5- to 11-year-old children.12 A Centers for Disease Control and Prevention study on over 400 000 children and adolescents across the United States reported that the monthly rate of BMI increase doubled between the prepandemic and pandemic periods.13 Additionally, pediatric patients who were overweight before the pandemic experienced higher monthly rates of BMI increase compared with children of healthy weight before the pandemic.13 In line with current literature, our study reports a rise in BMI and a higher prevalence of obesity among patients undergoing cholecystectomy during the pandemic at children’s hospitals across the western United States. Furthermore, our patient population was predominantly female and of Hispanic ethnicity. Although not surprising as increased BMI, female sex, and Hispanic ethnicity are all well-documented risk factors for gallstone disease,5,39 our findings allow for the development of targeted interventions for vulnerable subpopulations.

Ten years before the COVID-19 pandemic, 70% of pediatric inpatient admissions and 40% of pediatric general surgery operations took place in adult general hospitals.6,41 Therefore, the rise in cholecystectomy case volume could be due to increased transfer of pediatric patients from adult hospitals to alleviate the burden COVID-19 put on inpatient bed availability, similar to those reported in pediatric trauma centers.42 Indeed, we report an increase in the proportion of patients transferred from a referring hospital to 1 of the 10 participating children’s hospitals for inpatient surgery. Furthermore, transfer status does not capture changes in referral patterns across a large region nor does it account for existing patterns of regionalization of pediatric inpatient care over the last decade. Since 2008, pediatric inpatient units in the United States decreased by 19.1% and inpatient unit beds decreased by 11.8%, with rural areas seeing the sharpest declines.43 Pediatric beds are increasingly concentrated at children’s hospitals, with inpatient unit beds increasing 12.1% at children’s hospitals and decreasing 18.4% at adult general hospitals.43 Additionally, closures of pediatric inpatient units increased during and after the COVID-19 pandemic due to the need for adult beds and drive for increased profits.44 The pandemic acutely exacerbated and accelerated shifts that were already under way with respect to where pediatric care is delivered in the United States. Importantly, however, when transfer patients were excluded from the analysis, the sharp increase in month-to-month trend persisted, indicating that our results are likely multifactorial and cholecystectomy case counts cannot be explained by the changes in pediatric health care delivery alone.

The closing of pediatric units in general hospitals and similar shifts in the US health care system placed further strain on populations already at risk for poor access to care and may contribute to the increase in the presentation of complicated biliary disease at children’s hospitals. Notably, our results are limited to a racially and ethnically diverse group of children and adolescents, most of whom were publicly insured and cared for at institutions with large Hispanic populations. We report an increase in the proportion of Asian patients and a decrease in the proportion of Black patients treated with cholecystectomy during the pandemic at WPSRC institutions. Additionally, we report that the proportion of Hispanic patients treated with cholecystectomy increased during the pandemic at WPSRC institutions. It is important to note that Hispanic families have experienced disproportionately higher rates of COVID-19 infection, hospitalization, COVID-19–related mortality, and increased unemployment during the pandemic.24,25 Indeed, in our study, the proportion of patients undergoing cholecystectomy with public insurance increased and the proportion of those with private insurance decreased during the pandemic. The results of this study therefore add to our understanding of the unequal burden the COVID-19 pandemic placed on children from certain populations and their families. Although we also note an increase in the median ADI for both groups, this was not statistically significant. Additionally, we report a greater proportion of children in the middle ADI tertile and a decrease in those in the highest ADI tertile during the pandemic. It could be that the movement of the highest tertile prepandemic ADI scores to more moderate ADI scores in the pandemic group is due to the American Rescue Plan, which expanded the Child Income Tax credit.45 This law resulted in a substantial reduction in child poverty overall and marked the lowest child poverty rate on record, which may have lessened the differences seen due to ADI for this cohort as factors impacting ADI scores for the most vulnerable groups improved.45 Furthermore, the change in the distribution of ADI tertiles may support the view that despite the unequal impact on certain populations, changes in where pediatric care is delivered in the United States is impacting all pediatric patients.

Our study has several limitations. This study was performed at multiple institutions in the Western region of the United States, and it is unknown whether the findings observed are reflective of national trends. Although anecdotally each of the participating institutions experienced closures of pediatric inpatient beds at surrounding hospitals, specifics of these closures, timing, and whether temporary related to our findings is unknown. Additionally, any readmissions to a hospital other than the institution where surgery was performed were not captured. Although the demographic composition of the West is predominantly Hispanic, the US census predicts that Hispanic children will make up 31.9% of the pediatric population by 2060.46 Our results therefore may have future implications for pediatric health nationally. Additionally, the COVID-19 status of patients was not collected, and thus we cannot hypothesize whether infection with or exposure to the virus had any effect on our results reported. We elected not to explore the relationship between COVID-19 infection at time of cholecystectomy because of the changing accuracy of testing, emergence of new variants, inability to distinguish recent vs distant infection, and/or long–COVID-19. Although an association between COVID-19 and liver disease was identified,47 to our knowledge there are not studies in either the pediatric or adult population reporting an effect of COVID-19 on the biliary system. Although unlikely, we acknowledge that further investigation would be needed to determine whether COVID-19 is directly linked with pediatric biliary disease. Finally, in May 2023, the World Health Organization declared that COVID-19 no longer constituted a Public Health Emergency of International Concern.48 This retrospective study does not allow us to draw a causal link to COVID-19 pandemic alone unless a decrease in case volume to prepandemic levels was observed after the pandemic was declared over. However, cholecystectomy case volumes continued to rise even in the last 7 months of data collection in 2022 (Supplemental Table 1). Future studies are needed to determine whether the trends reported in this study represent a new baseline for pediatric health or were isolated to the COVID-19 pandemic.

Among hospitals participating in WPSRC, we observed a sharp rise in monthly cholecystectomy case volume and complexity during the COVID-19 pandemic. Children and adolescents undergoing cholecystectomy also had increased BMI and higher rates of obesity. The increase in pediatric cholecystectomy volume may be secondary to increases in childhood obesity, changes in transfer and referral patterns away from adult general hospitals, increasing the concentration of pediatric care to children’s hospitals, and other shifts in health care utilization that occurred during the COVID-19 pandemic.

Dr Kelley-Quon was the principal investigator responsible for study conception and design and data collection supervision. Drs Keane, Ignacio, and Kelley-Quon conceptualized the study with input and aid from Mr Ourshalimian. Drs Keane, Jensen, Rothstein, O’Guinn, Ms Ing, Drs Floan Sachs, Highet, Iantorno, Ms Templeton, Drs Ochoa, Patwardhan, Peace, Schwab, and Ms Tran aided in data collection. Mr Ourshalimian conducted the analyses, wrote initial drafts of the Methods and Statistical Analysis, and prepared tables and figures. Dr Keane drafted the manuscript. All authors provided feedback and crucial edits on drafts. Drs Keane, Kelley-Quon, and Mr Ourshalimian had full access to all data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

CONFLICT OF INTEREST DISCLOSURES: The authors have neither financial relationships nor conflicts of interest relevant to this article.

FUNDING: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

1
Doud
A
,
Bond
L
,
Downard
C
, et al
.
Management of complicated biliary disease in the pediatric population
.
Surgery.
2022
;
171
(
3
):
736
740
. PubMed doi: 10.1016/j.surg.2021.09.041
2
Bosley
ME
,
Zamora
IJ
,
Neff
LP
.
Choledocholithiasis—a new clinical pathway
.
Transl Gastroenterol Hepatol.
2021
;
6
:
35
. PubMed doi: 10.21037/tgh-20-172
3
Rothstein
DH
,
Harmon
CM
.
Gallbladder disease in children
.
Semin Pediatr Surg.
2016
;
25
(
4
):
225
231
. PubMed doi: 10.1053/j.sempedsurg.2016.05.005
4
Walker
SK
,
Maki
AC
,
Cannon
RM
, et al
.
Etiology and incidence of pediatric gallbladder disease
.
Surgery.
2013
;
154
(
4
):
927
933
. PubMed doi: 10.1016/j.surg.2013.04.040
5
Murphy
PB
,
Vogt
KN
,
Winick-Ng
J
,
McClure
JA
,
Welk
B
,
Jones
SA
.
The increasing incidence of gallbladder disease in children: a 20-year perspective
.
J Pediatr Surg.
2016
;
51
(
5
):
748
752
. PubMed doi: 10.1016/j.jpedsurg.2016.02.017
6
Sømme
S
,
Bronsert
M
,
Morrato
E
,
Ziegler
M
.
Frequency and variety of inpatient pediatric surgical procedures in the United States
.
Pediatrics.
2013
;
132
(
6
):
e1466
e1472
. PubMed doi: 10.1542/peds.2013-1243
7
Piltcher-da-Silva
R
,
Castro
TL
,
Trapp
AG
,
Bohnenberger
S
,
Kroth
EC
,
Pinto
JAR
,
Grehs
C
,
Tomasi
DC
,
Diemen
VV
,
Cavazzola
LT
.
The impact of COVID-19 and social avoidance in urgent and emergency surgeries—will a delay in diagnosis result in perioperative complications?
Rev Assoc Med Bras.
1992
;
67
(
3
):
355
359
. PubMed doi: 10.1590/1806-9282.20201000
8
Vallès
KF
,
Neufeld
MY
,
Caron
E
,
Sanchez
SE
,
Brahmbhatt
TS
.
COVID-19 pandemic and the cholecystitis experience at a major urban safety-net hospital
.
J Surg Res.
2021
;
264
:
117
123
. PubMed doi: 10.1016/j.jss.2021.02.037
9
Lapsekili
E
,
Buldanlı
MZ
,
Peker
YS
.
Comparison of outcomes of the patients with acute cholecystitis treated in the COVID-19 pandemic and pre-pandemic period
.
Rev Assoc Med Bras.
1992
;
67
(
11
):
1681
1686
. PubMed doi: 10.1590/1806-9282.20210727
10
Farber
ON
,
Gomez
GI
,
Titan
AL
, et al
.
Impact of COVID-19 on presentation, management, and outcomes of acute care surgery for gallbladder disease and acute appendicitis
.
World J Gastrointest Surg.
2021
;
13
(
8
):
859
870
. PubMed doi: 10.4240/wjgs.v13.i8.859
11
Gomez
D
,
Nantais
J
,
Telesnicki
T
, et al
.
A population-based analysis of the COVID-19 generated surgical backlog and associated emergency department presentations for inguinal hernias and gallstone disease
.
Ann Surg.
2022
;
275
(
5
):
836
841
. PubMed doi: 10.1097/SLA.0000000000005403
12
Woolford
SJ
,
Sidell
M
,
Li
X
, et al
.
Changes in body mass index among children and adolescents during the COVID-19 pandemic
.
JAMA.
2021
;
326
(
14
):
1434
1436
. PubMed doi: 10.1001/jama.2021.15036
13
Lange
SJ
,
Kompaniyets
L
,
Freedman
DS
, et al;
DNP3
.
Longitudinal trends in body mass index before and during the COVID-19 pandemic among persons aged 2–19 years—United States, 2018–2020
.
MMWR Morb Mortal Wkly Rep.
2021
;
70
(
37
):
1278
1283
. PubMed doi: 10.15585/mmwr.mm7037a3
14
Yang
S
,
Guo
B
,
Ao
L
, et al
.
Obesity and activity patterns before and during COVID-19 lockdown among youths in China
.
Clin Obes.
2020
;
10
(
6
):
e12416
. PubMed doi: 10.1111/cob.12416
15
Yang
D
,
Luo
C
,
Feng
X
, et al
.
Changes in obesity and lifestyle behaviours during the COVID-19 pandemic in Chinese adolescents: a longitudinal analysis from 2019 to 2020
.
Pediatr Obes.
2022
;
17
(
5
):
e12874
. PubMed doi: 10.1111/ijpo.12874
16
Brooks
CG
,
Spencer
JR
,
Sprafka
JM
, et al
.
Pediatric BMI changes during COVID-19 pandemic: an electronic health record-based retrospective cohort study
.
EClinicalMedicine.
2021
;
38
:
101026
. PubMed doi: 10.1016/j.eclinm.2021.101026
17
Cena
H
,
Fiechtner
L
,
Vincenti
A
, et al
.
COVID-19 pandemic as risk factors for excessive weight gain in pediatrics: the role of changes in nutrition behavior. A narrative review
.
Nutrients.
2021
;
13
(
12
):
4255
. PubMed doi: 10.3390/nu13124255
18
Chioma
L
,
Bizzarri
C
,
Verzani
M
, et al
.
Sedentary lifestyle and precocious puberty in girls during the COVID-19 pandemic: an Italian experience
.
Endocr Connect.
2022
;
11
(
2
):
e210650
. PubMed doi: 10.1530/EC-21-0650
19
Koletzko
B
,
Holzapfel
C
,
Schneider
U
,
Hauner
H
.
Lifestyle and body weight consequences of the COVID-19 pandemic in children: increasing disparity
.
Ann Nutr Metab.
2021
;
77
(
1
):
1
3
. PubMed doi: 10.1159/000514186
20
Androutsos
O
,
Perperidi
M
,
Georgiou
C
,
Chouliaras
G
.
Lifestyle changes and determinants of children’s and adolescents’ body weight increase during the first COVID-19 lockdown in Greece: the COV-EAT study
.
Nutrients.
2021
;
13
(
3
):
930
. PubMed doi: 10.3390/nu13030930
21
Medrano
M
,
Cadenas-Sanchez
C
,
Oses
M
,
Arenaza
L
,
Amasene
M
,
Labayen
I
.
Changes in lifestyle behaviours during the COVID-19 confinement in Spanish children: a longitudinal analysis from the MUGI project
.
Pediatr Obes.
2021
;
16
(
4
):
e12731
. PubMed doi: 10.1111/ijpo.12731
22
Pietrobelli
A
,
Fearnbach
N
,
Ferruzzi
A
, et al
.
Effects of COVID-19 lockdown on lifestyle behaviors in children with obesity: longitudinal study update
.
Obes Sci Pract.
2022
;
8
(
4
):
525
528
. PubMed doi: 10.1002/osp4.581
23
Keane
OA
,
Ourshalimian
S
,
O’Guinn
M
,
Ing
M
,
Odegard
M
,
Ignacio
R
,
Kelley-Quon
LI
.
Increases in pediatric cholecystectomy during the COVID-19 pandemic: an interrupted time series analysis
.
Surgery.
2024
;
175
(
2
):
304
310
. doi: 10.1016/j.surg.2023.10.027.
24
Mackey
K
,
Ayers
CK
,
Kondo
KK
, et al
.
Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: a systematic review
.
Ann Intern Med.
2021
;
174
(
3
):
362
373
. PubMed doi: 10.7326/M20-6306
25
Liao
KT
,
Villarreal
A
.
Unequal effects of the COVID-19 epidemic on employment: differences by immigrant status and race/ethnicity
.
PLoS One.
2022
;
17
(
11
):
e0277005
. PubMed doi: 10.1371/journal.pone.0277005
26
Neighborhood Atlas
.
Center for Health Disparities Research
. University of Wisconsin School of Medicine and Public Health. Accessed May 31, 2023. https://www.neighborhoodatlas.medicine.wisc.edu/
27
Singh
GK
.
Area deprivation and widening inequalities in US mortality, 1969–1998
.
Am J Public Health.
2003
;
93
(
7
):
1137
1143
. PubMed doi: 10.2105/AJPH.93.7.1137
28
Sykes
AG
,
Rooney
AS
,
Avila
AG
, et al
.
Pediatric trauma in the California-Mexico border region: injury disparities by Area Deprivation Index
.
J Trauma Acute Care Surg.
2022
;
92
(
5
):
831
838
. PubMed doi: 10.1097/TA.0000000000003553
29
Michaels
AD
,
Meneveau
MO
,
Hawkins
RB
,
Charles
EJ
,
Mehaffey
JH
.
Socioeconomic risk-adjustment with the Area Deprivation Index predicts surgical morbidity and cost
.
Surgery.
2021
;
170
(
5
):
1495
1500
. PubMed doi: 10.1016/j.surg.2021.02.016
30
Power
R
.
Neighborhood socioeconomic disparities impact pediatric access to surgical care
. Presented at the: 16th Annual Academic Surgical Congress; February 4, 2021; Virtual.
31
Purcell
LN
,
Bartley
C
,
Purcell
ME
,
Cairns
BA
,
King
BT
,
Charles
A
.
The effect of neighborhood Area Deprivation Index on residential burn injury severity
.
Burns.
2021
;
47
(
2
):
447
454
. PubMed doi: 10.1016/j.burns.2020.07.014
32
Penfold
RB
,
Zhang
F
.
Use of interrupted time series analysis in evaluating health care quality improvements
.
Acad Pediatr.
2013
;
13
(6)(
suppl
):
S38
S44
. PubMed doi: 10.1016/j.acap.2013.08.002
33
Wagner
AK
,
Soumerai
SB
,
Zhang
F
,
Ross-Degnan
D
.
Segmented regression analysis of interrupted time series studies in medication use research
.
J Clin Pharm Ther.
2002
;
27
(
4
):
299
309
. PubMed doi: 10.1046/j.1365-2710.2002.00430.x
34
Schaffer
AL
,
Dobbins
TA
,
Pearson
SA
.
Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions
.
BMC Med Res Methodol.
2021
;
21
(
1
):
58
. PubMed doi: 10.1186/s12874-021-01235-8
35
Waldhausen
JH
,
Benjamin
DR
.
Cholecystectomy is becoming an increasingly common operation in children
.
Am J Surg.
1999
;
177
(
5
):
364
367
. PubMed doi: 10.1016/S0002-9610(99)00063-X
36
Balaguer
EJ
,
Price
MR
,
Burd
RS
.
National trends in the utilization of cholecystectomy in children
.
J Surg Res.
2006
;
134
(
1
):
68
73
. PubMed doi: 10.1016/j.jss.2006.02.053
37
Vegunta
RK
,
Raso
M
,
Pollock
J
, et al
.
Biliary dyskinesia: the most common indication for cholecystectomy in children
.
Surgery.
2005
;
138
(
4
):
726
733
. PubMed doi: 10.1016/j.surg.2005.06.052
38
Preston
JF
,
Diggs
BS
,
Dolan
JP
,
Gilbert
EW
,
Schein
M
,
Hunter
JG
.
Biliary dyskinesia: a surgical disease rarely found outside the United States
.
Am J Surg.
2015
;
209
(
5
):
799
803
. PubMed doi: 10.1016/j.amjsurg.2015.01.003
39
Mehta
S
,
Lopez
ME
,
Chumpitazi
BP
,
Mazziotti
MV
,
Brandt
ML
,
Fishman
DS
.
Clinical characteristics and risk factors for symptomatic pediatric gallbladder disease
.
Pediatrics.
2012
;
129
(
1
):
e82
e88
. PubMed doi: 10.1542/peds.2011-0579
40
Santucci
NR
,
Hyman
PE
,
Harmon
CM
,
Schiavo
JH
,
Hussain
SZ
.
Biliary dyskinesia in children: a systematic review
.
J Pediatr Gastroenterol Nutr.
2017
;
64
(
2
):
186
193
. PubMed doi: 10.1097/MPG.0000000000001357
41
Leyenaar
JK
,
Ralston
SL
,
Shieh
MS
,
Pekow
PS
,
Mangione-Smith
R
,
Lindenauer
PK
.
Epidemiology of pediatric hospitalizations at general hospitals and freestanding children’s hospitals in the United States
.
J Hosp Med.
2016
;
11
(
11
):
743
749
. PubMed doi: 10.1002/jhm.2624
42
Flynn-O’Brien
KT
,
Collings
AT
,
Farazi
M
, et al;
Midwest Pediatric Surgery Consortium
.
Pediatric injury transfer patterns during the COVID-19 pandemic: an interrupted time series analysis
.
J Surg Res.
2023
;
281
:
130
142
. PubMed doi: 10.1016/j.jss.2022.08.029
43
Cushing
AM
,
Bucholz
EM
,
Chien
AT
,
Rauch
DA
,
Michelson
KA
.
Availability of pediatric inpatient services in the United States
.
Pediatrics.
2021
;
148
(
1
):
e2020041723
. PubMed doi: 10.1542/peds.2020-041723
44
Baumgaertner
E
.
As hospitals close children’s units, where does that leave Lachlan?
The New York Times.
May 8, 2022. Accessed January 23, 2024. https://www.nytimes.com/2022/10/11/health/pediatric-closures-hospitals.html
45
Wimer
C
,
Collyer
S
,
Harris
D
,
Lee
J
.
The 2021 Child Tax Credit expansion: child poverty reduction and the children formerly left behind
.
Poverty and Social Policy Brief.
2022
;
6
(
8
):
1
14
.
46
Vespa
J
,
Medina
L
,
Armstrong
DM
.
Demographic Turning Points for the United States: Population Projections for 2020 to 2060, Population Estimates and Projections
.
United States Census Bureau
;
2018
. Accessed January 23, 2024. https://www.census.gov/content/dam/Census/library/publications/2020/demo/p25-1144.pdf
47
Cooper
S
,
Tobar
A
,
Konen
O
, et al
.
Long COVID-19 liver manifestation in children
.
J Pediatr Gastroenterol Nutr.
2022
;
75
(
3
):
244
251
. PubMed doi: 10.1097/MPG.0000000000003521
48
Roknuzzaman
ASM
,
Sarker
R
,
Nazmunnahar
,
Shahriar
M
,
Al Mosharrafa
R
,
Islam
MR
.
The WHO has declared COVID-19 is no longer a pandemic-level threat: a perspective evaluating potential public health impacts
.
Clin Pathol.
2024
;
17
. doi: 10.1177/2632010X241228053.

Supplementary data